RIKER LAUREN 4
4 · Pacira BioSciences, Inc. · Filed Jun 5, 2025
Insider Transaction Report
Form 4
RIKER LAUREN
Senior Vice President, Finance
Transactions
- Tax Payment
Common Stock
2025-06-03$26.40/sh−3,374$89,074→ 65,142.335 total - Sale
Common Stock
2025-06-04$26.21/sh−5,578.335$146,208→ 59,564 total
Footnotes (2)
- [F1]Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.15 to $26.38, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2.